We further identified ten core targets (SRC, PIK3R1, CTNNB1, FYN, CTNNA1, RAC1, EGFR, LCK, ABL1, and PTPN1) that may mediate Icaritin’s anti-HCC action. Here, CTNNB1 is linked to hepatocellular carcinoma.